ASST has surged nearly 48% in five sessions, but the lending market tells a story of shorts still firmly in place — with a borrow pool that only just began to loosen after weeks of near-zero availability.
The most striking feature of this week's setup is what happened in the borrow market. For most of July and into early August, availability on ASST was effectively zero — every share in the lending pool was out on loan. That began to shift last week, and by August 20 availability had climbed to 24.3%, a dramatic improvement from the 0% floor that persisted for over a month. The movement is notable: availability jumped more than 300% week-on-week, but at roughly one share available for every four already borrowed, the borrow market is still tight by any normal standard. Cost to borrow, at 1.52%, is modest — up around 9% on the week but well below levels that would suggest serious short squeeze pressure. Short interest itself has edged down about 3% on the week to 3.5% of free float, a level that on its own would rarely earn much attention. The real story is the sequencing: availability was locked shut during the stock's initial run, and has only now cracked open as the price has moved sharply higher.
Options positioning adds a layer to the picture. The put/call ratio jumped to 0.14 on August 21, which sounds low in absolute terms but represents the most defensive reading in months relative to its own history — running more than 2.6 standard deviations above the 20-day mean of 0.11. Call positioning has dominated this name for weeks, so even a modest uptick in put buying stands out. The 52-week high on the PCR is 1.98, meaning the options market overall remains heavily skewed toward calls, but the sharp one-day move in the ratio on Friday hints that at least some participants are beginning to hedge a position that has nearly doubled in a month.
Analyst coverage is uniformly bullish, though targets have been drifting lower. HC Wainwright trimmed its target to $36 earlier this month while holding a Buy. TD Cowen cut to $28 in late July from $32. The consensus mean sits at $26.60 — now only modestly above the current $18.22 price after the week's rally, compared to a much wider gap just weeks ago. The bull case centres on Strive's Bitcoin-focused structured finance strategy and its partnership with Strategy, which the Street argues gives it a competitive edge in BTC treasury accumulation. The bear case is direct: the model is highly exposed to cryptocurrency volatility, funded partly through equity issuance that risks shareholder dilution, and the NAV is sensitive to swings in BTC prices that Strive cannot control. EPS surprise ranks in the 99th percentile of the ORTEX universe — the company has consistently beaten estimates — but valuation multiples are negative across the board, reflecting ongoing losses, and the short score of 73.9 places ASST firmly in the top quartile of names with elevated short-side pressure.
Institutional flow shows genuine demand building. FMR added 2.7 million shares as of June 30, lifting its stake to 11.6% of shares. BlackRock added 1.6 million shares through July 31, reaching 6.2%. Jane Street added 1.8 million shares over the same period. Against that, co-founder Vivek Ramaswamy trimmed nearly 1.4 million shares as of late May — a reduction worth watching given his founding role. A director made a small open-market purchase of around $200,000 on August 14, at $12.54, well below the current price — a signal of conviction at levels the stock has now blown through.
Correlated names moved sharply too, though well below ASST's pace: SKYA gained 33% on the week and HSDT added 24%, while NUWE dropped 11%. The breadth of the move across the peer group suggests sector-level momentum, but ASST's 48% print dwarfs those in the cohort. With no next earnings event currently scheduled and the stock having now reclaimed a price well above where most institutional buying was disclosed, the key variable to track is whether borrow availability continues to expand — and whether fresh short interest re-enters at these higher levels or the squeeze dynamics exhaust themselves first.
See the live data behind this article on ORTEX.
Open ASST on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
